Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer.
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer. Breast Cancer Res. 2008; 10(4):R60.